been developed in Spring 2026 with significant input from key partners, including public contributors. It will be submitted to NIHR in August 2026 and will take effect from 1 April 2027. Progress will be overseen by the R&D Committee.

7.7. The Oxford BRC held a joint Health Research Showcase with the Oxford Health BRC at the Westgate Shopping Centre on 29 May 2025. This is an opportunity to showcase the broad range of research that takes place in Oxford, how it benefits NHS patients and how members of the public can get involved in clinical trials.

7.8. The Oxford BRC holds regular public talks, aimed at engaging the public in its research, recordings of which are available on the BRC's YouTube channel.

8. NIHR Oxford Clinical Research Facility (Oxford CRF)

8.1. The Oxford CRF is an NIHR-funded facility that provides the specialist environment and staff to deliver early-phase and experimental clinical research. It is hosted by OUH and delivered in partnership with the University of Oxford, facilitated by a Collaboration Agreement between both organisations.

8.2. Now in its fourth year of operation, the Oxford CRF has continued to expand the scope and volume of activity in line with its strategic objectives. Highlights for 2025-26 include:

8.3. Over 43 studies supported within the Oxford CRF. This is a 43% increase compared to 2024-25. 30 of the studies supported in 2025-26 were commercially sponsored.

8.4. 129 flexi-sigmoidoscopies and 50 bronchoscopy procedures have been delivered for clinical research studies, representing a steady increase in procedural support activity for research studies.

8.5. Working with commercial partners and haematology colleagues – medical and nursing – set-up the first non-oncology CAR-T study to recruit participants at OUH.

8.6. Working with colleagues in the Oxford BRC to develop the institutional PPIE strategy required by the NIHR, and hosting PPIE events in the CRF.

8.7. Following a successful OUH bid for additional funds from the NIHR, preparations are being made for the Oxford CRF, along with the Oxford Experimental Cancer Medicine Centre (ECMC), to pilot a cloud-based system for managing essential study documentation (the Investigator Site File (ISF)) for new studies being set-up during 2026-